passage bio inc stock price

Saturday, October 15, 2022 Edit

Passage Bio Inc NASDAQ Updated Oct 14 2022 652 PM. For the fiscal year ended 31 December 2021 Passage Bio Inc revenues was not reported.

Passage Bio Inc

Stock information by Barrons.

. PASG stock forecast and price target Find the latest Passage Bio Inc. Oct 14 41426 PM GMT-4 USD NASDAQ Disclaimer. Real time Passage Bio Inc.

NASDAQ USD Post-Market. Chous initial equity grant Passage Bio granted options to purchase 665500 shares of common stock to Dr. 128 -002 -154 408 PM.

Is 283 for 2027 Jun. The Company is focused on developing transformative therapies for central nervous. PASG Passage Bio IncStock Price Overview.

In June 2022 Passage Bio had US239m in cash and was debt-free. 11 hours agoAs part of Dr. Importantly its cash burn.

Get the latest Passage Bio Inc PASG detailed stock quotes stock data Real-Time ECN charts stats and more. 619a Ambarella stock price target cut to 100 from 120 at KeyBanc Capital. Nasdaq AT CLOSE 400 PM EDT 081922.

11 hours agoThe stock options have an exercise price of 132 per share which is equal to the closing price of Passage Bios common stock on October 10 2022 the grant date of the options. Net loss increased 65 to 1854M. A companys cash runway is calculated by dividing its cash hoard by its cash burn.

Company facts information and financial ratios from MarketWatch. Higher net loss reflects Research and development. The current Passage Bio PASG share price is 132.

Chou as material inducements to employment in. According to 14 analysts the average rating for PASG stock is Buy The 12-month stock price forecast is 976 which is an increase of 62296 from the latest price. PASG stock price quote stock graph news analysis.

Complete Passage Bio Inc. Not an offer or recommendation by Stocktwits. AFTER HOURS 404 PM EDT 081922.

PASSAGE BIO INC. 11 hours agoThe stock options have an exercise price of 132 per share which is equal to the closing price of Passage Bios common stock on October 10 2022 the grant date of the. Fulfilling the promise of gene therapy using a distinctive research and development model to transform the lives of patients with central nervous system CNS disorders.

Is a clinical stage genetic medicines company. The stock options have an exercise price of 132 per share which is equal to the closing price of Passage Bios common stock on October 10 2022 the grant date of the. Passage Bio Inc 163.

View real-time PASG stock price and news along with industry-best analysis. Stock analysis for Passage Bio Inc PASGNASDAQ GS including stock price stock chart company news key statistics fundamentals and company profile. View Passage Bio Inc PASG investment stock information.

130 -002 -152 400 PM 101122.

Pasg Stock Price And Chart Nasdaq Pasg Tradingview